Steven Katz

Company: TriSalus Life Sciences

Job title: Chief Medical Officer

Seminars:

TME Modelling & Dose Optimization for Solid Tumor Immunotherapy Development – the TriSalus Translational & Clinical Experience 1:00 pm

Addressing organ-specific immunosuppressive barriers through strategic MoA selection Reflect on the integration of appropriate delivery strategies to enable therapeutic performance Analyze the selection of immunologic read-outs for early phase clinical trials to enable detection of biologic activityRead more

day: Conference Day 1